NJ-CRYPTOS-FUND
12.4.2018 17:03:05 CEST | Business Wire | Press release
Cryptos Fund , the first regulated cryptocurrency index fund, announces the launch of a new entity dedicated to qualified investors.
Cryptos Fund (US) is based in Princeton, NJ, and is managed by Hermes Asset Management, with a team lead by Igor Rivin, one of the world’s most respected mathematicians, and a professor of Mathematics at Temple University. The fund tracks the CCi30 index of the 30 main cryptocurrencies, thus allowing investors to gain exposure to the entire Blockchain sector.
“The blockchain sector is still in its infancy and has enormous growth potential,” says Dr. Igor Rivin, the Chief Research Officer. “Institutional investors have just started to enter this sector; we expect more and more players of the caliber of George Soros to join the field in the future. We believe that following the CCi30 index is a smart way to invest in cryptocurrencies. While we have no crystal ball, we feel that this is the most prudent way to explore the market.”
Jeffrey Zorn, the Chief Security Officer, says: “The fund is the best instrument for participating in the growth of cryptocurrencies and the blockchain technology, which is one of the three most important inventions of the last 50 years, together with silicon and the internet. Cryptos Fund provides the highest levels of security: counterparty risk has been completely neutralized, and the assets are held in our proprietary cold storage, with redundant facilities and military-level physical protection.” Jeffrey Zorn is a global security expert, Major, USMC, recipient of the Bronze Star Medal with Valor device, and former military aide to the U.S. president at the White House. In this role he carried the “football,” the briefcase containing the codes of the U.S. nuclear arsenal. Today Zorn consults multinational corporations and governments on security matters and is responsible for all the security aspects of Cryptos Fund.
The following top quality service providers are employed by the fund: Trident Trust, administrator; Baker Tilly, auditor; Morgan, Lewis & Bockius, legal advisor; and BMO Harris, banker.
Cryptos Fund accepts subscriptions from qualified investors starting from $10,000. It doesn’t charge subscription, redemption or performance fees, while the management fee is as low as 0.99%, depending on the size of the subscription.
Investors wishing to participate in Cryptos Fund (US) can visit www.thecryptos.fund .
View source version on businesswire.com: https://www.businesswire.com/news/home/20180412005867/en/
Contact:
Cryptos Fund
Ariel Schulz, +1.609.375.8508
info@thecryptosfund.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. Federal Court Permanently Bans 19 Online Sellers of Fake Urolithin A Supplements and Awards $5.3 Million in Damages to Timeline23.7.2026 16:27:00 CEST | Press release
Default judgment follows Timeline’s independent laboratory testing showing products sold under 19 online brands contained no detectable Urolithin A, or far less than advertised Timeline (Amazentis SA), the Swiss life-sciences company that pioneered the postbiotic ingredient Urolithin A and its branded form Mitopure®, together with its U.S. subsidiary Timeline Longevity, Inc., announced today that the U.S. District Court for the District of Massachusetts has granted the companies’ motion for default judgments and permanent injunctions against 19 online sellers found to have marketed and sold nutritional supplements falsely advertised as containing Urolithin A. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260722951066/en/ Timeline longevity supplement powered by Mitopure; proprietary, highly pure Urolithin A. The order, entered July 15, 2026 by Judge Myong J. Joun in Amazentis SA et al. v. The Partnerships and Unincorporated
TestMu AI Introduces the Source-to-Verdict Loop in Kane CLI, Carrying Every Requirement to a Ship Decision With Portable Proof23.7.2026 15:45:00 CEST | Press release
Kane CLI now takes a requirement all the way to a ship-or-hold verdict, designing the tests, running them in a real browser, and emitting an open .evidence proof pack that teammates, AI agents, and auditors can all verify, with no server or dashboard required TestMu AI (formerly LambdaTest), the world's first Agentic AI-powered Quality Engineering platform, introduced a source-to-verdict loop in Kane CLI, its natural-language testing tool. Building on Kane CLI's evolution from a browser automation tool, the loop carries a product requirement to a ship decision, writing the tests, running them in the local browser, collecting the proof, measuring coverage from what actually happened, and returning a verdict. As AI agents write, run, and fix tests, a green checkmark is no longer enough: a step that checks nothing passes, a test written against a spec that changed weeks ago passes, and an agent that says “done” without the click ever landing passes. Empty green and earned green are the sa
Norway’s health system adopts Wolters Kluwer UpToDate Enterprise Edition23.7.2026 15:30:00 CEST | Press release
Enterprise Clinical Decision Support solution available to 30,000 clinicians in more than 50 Norwegian hospitals Wolters Kluwer Health announced that Norway’s health system has renewed its adoption of UpToDate Enterprise Edition, a market-leading Clinical Decision Support (CDS) solution, for its nationwide health system which includes over 50 public hospitals and 11,000 beds in over 20 trusts. This extends a 15 year partnership with Helsebiblioteket, now part of the Norwegian Institute of Public Health (NIPH). Helping clinicians on a national scale Kjell Tjensvoll, Team Leader for Helsebiblioteket said, ‘‘Providing frontline teams with easy access to the latest medical knowledge is vital in reducing unwarranted variation and improving patient care on a national scale. UpToDate Enterprise Edition enables this, and we are delighted to strengthen our relationship with Wolters Kluwer and provide continued support for clinicians across the country.’’ UpToDate Enterprise Edition was selected
Boyd Watterson Global Names John Creswell Global Chief Client Officer to Accelerate Global Growth and Client Engagement23.7.2026 15:00:00 CEST | Press release
Veteran investment management executive will lead global sales, client engagement and marketing as Boyd Watterson Global continues expanding its global alternatives platform across real estate, infrastructure, and debt strategies. Boyd Watterson Global today announced the appointment of John Creswell as Global Chief Client Officer, a newly created senior leadership role that reflects the firm's continued investment in growth and its evolution into a leading global alternatives investment platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260722823117/en/ John Creswell has joined Boyd Watterson Global as Global Chief Client Officer, a newly created role overseeing global sales, client engagement and marketing across the U.S., Europe and APAC. In this role, Creswell will oversee global sales, client engagement and marketing efforts across the United States, Europe and APAC, helping investors access the firm's capabilitie
Trulioo Launches AI Agent to Resolve Beneficial Ownership Where Global Registries Fall Short23.7.2026 15:00:00 CEST | Press release
Breakthrough AI agent reconstructs ownership for long-tail businesses and hard-to-reach jurisdictions while significantly increasing UBO coverage Trulioo, a global risk intelligence platform, today announced the UBO Discovery Agent, the newest layer in Trulioo's UBO Discovery capability inside its business risk and Know Your Business (KYB) verification workflow. AI is reshaping fraud, making it easier for bad actors to hide, and harder for companies to catch them. This makes the already tough job of verifying who actually owns a business even more difficult. Determining a business's ultimate beneficial owner is an ongoing, acute challenge for companies: registry coverage is inconsistent across countries, and even where registries exist, they typically record shareholders and directors of record (rather than the people actually in control). That data isn't simply outdated, it reflects a structural lag: ownership changes and time passes before the filing is made and processed, so a looku
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom